What is Rti?
Rti, LLC is a distinguished veterinary contract research organization established in 1994, specializing in animal health and biomedical research. The company provides a comprehensive suite of services, including pre-clinical and clinical research, diagnostics, and regulatory affairs support, catering to clients in the biopharma and advanced nutrition industries. Leveraging deep expertise in pharmacology, vaccinology, and immunology, Rti conducts studies adhering to Good Laboratory Practice (GLP) and Good Clinical Practice (GCP) standards. Its long-standing reputation as a trusted partner for global clients underscores its pivotal role in advancing health and welfare sectors through rigorous scientific investigation.
How much funding has Rti raised?
Rti has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Rti?
The substantial capital infusion, characterized as a large-scale late-stage funding event, positions Rti for accelerated growth and strategic expansion. This financing is expected to bolster its capabilities in pre-clinical and clinical research, potentially enabling the company to take on more complex projects and broaden its service portfolio. The strategic investment signals confidence from backers in Rti's market leadership and its potential to further innovate within the veterinary and biomedical research landscape. Future developments may include enhanced diagnostic services, expanded regulatory support, and deeper penetration into global biopharma markets.
See full Rti company page
